Hadox Research Labs · Science Intelligence
We watch the research landscape, compare papers with fair peers, read the full text and publish the receipts. No journal logo, citation count or model gets the last word alone.
Current truthThe ascendance engine is still building history. This edition is editorially selected, not algorithmically declared “rising.”
Comparison universe1,138 current candidates across 41 age, field and article-type cohorts.
Evidence gateEvery public dossier was read from an authorised full body. Abstract-only records remain ineligible.
As of25 Jul 2026
This public, sanitized index unites the observatory with Hadox's reviewed dossiers. Bibliographic metadata and measured signal states are visible; abstracts and source text are not.
Tracking is not endorsement. A row means Hadox is monitoring the paper or has completed a public dossier. Radar states appear only when measured against age-, field- and article-type peers; no metric is invented for editorial selections.
Read the selection method| Paper | Field | Radar state | Attention | Next review | Hadox |
|---|---|---|---|---|---|
| The next steps for chronic kidney disease The Lancet · 2026-06-01 · 10.1016/s0140-6736(26)01183-9 | Nephrology Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 30% · 5 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| The rise of polyploids during environmental upheaval Cell · 2026-06-01 · 10.1016/j.cell.2026.04.008 | Plant Science Research article | Baseline Candidate · 1 signal point | 7 citations Cohort 94% · 8 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| The unfinished path towards patient safety The Lancet · 2026-06-01 · 10.1016/s0140-6736(26)01192-x | Health Sciences Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 35% · 90 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Transposable element DNA and RNA: Drivers of gene expression, evolution, and disease Cell · 2026-06-01 · 10.1016/j.cell.2026.05.003 | Plant Science Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 44% · 8 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Treatment potential of oral small-molecule GLP-1 receptor agonists The Lancet · 2026-06-01 · 10.1016/s0140-6736(26)01135-9 | Medicine Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 34% · 86 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| UNAIDS: HIV control hit hard by aid cuts The Lancet · 2026-06-01 · 10.1016/s0140-6736(26)01238-9 | Medicine Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 34% · 86 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Virological characteristics of SARS-CoV-2-related coronaviruses dynamically circulating in Southeast Asia Cell · 2026-06-01 · 10.1016/j.cell.2026.04.019 | Infectious Diseases Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 39% · 9 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| When health-care workers become the target in Lebanon The Lancet · 2026-06-01 · 10.1016/s0140-6736(26)01103-7 | Social Sciences Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 39% · 9 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| WHO and Africa CDC declare the 2026 Ebola disease outbreak a public health emergency The Lancet · 2026-06-01 · 10.1016/s0140-6736(26)01101-3 | Infectious Diseases Research article | Baseline Candidate · 1 signal point | 2 citations Cohort 83% · 9 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| WHO and Africa CDC launch $518 million Ebola plan The Lancet · 2026-06-01 · 10.1016/s0140-6736(26)01184-0 | Infectious Diseases Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 39% · 9 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Why it’s time to bin recommendation letters in science job applications Nature · 2026-06-01 · 10.1038/d41586-026-00507-x | Social Sciences Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 45% · 21 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Why medicine needs literary magazines The Lancet · 2026-06-01 · 10.1016/s0140-6736(26)01250-x | Life Sciences Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 34% · 67 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Xenophagocytosis blockade enhances interspecies chimerism Cell · 2026-06-01 · 10.1016/j.cell.2026.05.016 | Immunology and Microbiology Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 43% · 7 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Selpercatinib in Early-Stage RET Fusion–Positive Non–Small-Cell Lung Cancer The New England Journal of Medicine · 2026-05-31 · 10.1056/nejmoa2602628 | Pulmonary and Respiratory Medicine Research article | Baseline Candidate · 1 signal point | 2 citations Cohort 50% · 6 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| PARP and Androgen-Signaling Inhibition plus ADT in Metastatic Prostate Cancer The New England Journal of Medicine · 2026-05-30 · 10.1056/nejmoa2604126 | Oncology Research article | Baseline Candidate · 1 signal point | 2 citations Cohort 67% · 12 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
These are the exact visual editions already shared by Hadox. Each one now has a canonical source, immutable assets and a visible workflow state; publication history never substitutes for scientific review.
01
The source is identified, but no authorised full body is available for Hadox review yet.
02
Published edition linked to a full-text Hadox evidence dossier.
03
This official-source story is awaiting the institutional evidence workflow.
Historical copy retained; correction logged in the workflow.
Today, 0 papers have enough history for a momentum score and 0 public dossiers were selected by an open ascendance gate. That is not a failure to hide; it is the calibration state.
current paper assessments from Crossref + Openalex
cohorts split by paper age, article type and discipline
baseline · 1 watch · 0 rising
01Observe attention against fair peers.
02Wait for enough history to measure velocity.
03Read the authorised full paper and map every claim.
04Make a separate editorial decision and publish the evidence.